Emergent BioSolutions to expand market of anthrax vaccine, BioThrax, in Europe
by Press Release from Outbreak News Today on (#3MSFF)
Emergent BioSolutions Inc. announced this week the successful completion of the Mutual Recognition Procedure (MRP) for market authorization of BioThrax(R) (Anthrax Vaccine Adsorbed) in five Concerned Member States (CMS) within the European Union (EU), including Italy, the Netherlands, Poland, the U.K., and France (where it will be marketed as BaciThraxa). Emergent filed the mutual recognition application based on the existing Marketing Authorization of BioThrax ["]
The post Emergent BioSolutions to expand market of anthrax vaccine, BioThrax, in Europe appeared first on Outbreak News Today.